Metabolic or synthetic N-hydroxylation of N-arylamides yields N-arylacylhydroxamic acids considerably more carcinogenic for the rat mammary gland than the parent amides both by systemic and topical administration. The size of the aryl moiety, the position of the nitrogen relative to the aryl moiety and the type of acyl group are determinants of the carcinogenic potency of N-arylacylhydroxamic acids. Induction of mammary tumors required ovarian hormones. Receptors for estrogen, androgen and progesterone were shown in the N-hydroxy-N-2-fluorenylacetamide (N-OH-2-FAA)induced mammary carcinoma. This tumor involved epithelial and stromal components of the mammary gland that were separated in culture and produced tumors of their respective origin in the isologous host. Both mammary epithelial cells and fibroblasts are capable of metabolism of carcinogens. The enzymes potentially involved in metabolic activation of N-arylamides and Narylacylhydroxamic acids in the mammary gland include: a cytochrome P-450(P,-450) system, UDPglucuronyltransferase, N,O-acyltransferases and peroxidases. Mammary microsomes in which cytochrome P,-450 was induced generated small amounts of N-OH-2-FAA from 2-FAA. N-OH-2-FAA and its carcinogenic isomer, N-OH-3-FAA, were oxidized by cytochrome c/H202 to the nitroxyl free radicals which dismutated to the respective acetate esters and nitrosofluorenes. The addition of unsaturated lipid to either the free radicals or to the nitrosofluorenes gave electron spin resonance signals characteristic of immobilized radicals. It is proposed that interactions of carcinogens with lipids and with DNA play a role in mammary tumorigenesis.
the N-arylamides and synthetic N-hydroxylation yielded hydroxamic acids with greater carcinogenic potency for the rat mammary gland. The size and shape of the aryl moiety was a determinant of its potency since the fluorenyl compounds even at lower doses were more carcinogenic than the biphenylyl compounds. The N-phenyl series was shown to be much less, if at all, carcinogenic (3) . The type of N-acyl moiety also affected carcinogenic activity, since the N-formyl and N-propionyl compounds in the biphenylyl series were less carcinogenic than the N-acetyl compound (5) . The effect of the position of nitrogen relative to the N-aryl moiety was also determined (Table 2) (3, (6) (7) (8) . Although differences in the carcinogenicities of 2-FAA and Nhydroxy-2-FAA could be detected at about 6 months after administration (Table 1) , these compounds produced similarly high incidences of mammary tumors when assessed 12 months after administration (6) . In contrast to 2-FAA, the structural isomers, 1-, 3-and 4-FAA were weakly, if at all, carci-nogenic (3, 7, 8) . N-Hydroxylation of 3-FAA and, to a lesser extent, of 1-FAA yielded hydroxamic acids with increased carcinogenicities for the rat mammary gland (3); however, N-hydroxylation of 4-FAA did not increase its carcinogenicity (7) . In subsequent metabolic studies ( Table 3 ) we showed that the weakly carcinogenic 3-FAA was not N-hydroxylated by the liver of the female rat in vivo (9) or in vitro (10) . In contrast, substantial amounts of carcinogenic 2-FAA were converted to N-hydroxy-2- Table 1 b12 IP injections at a dose level of 0.2 (F-series) (1) (3, 6, 7) . bNumbers in parentheses are the percent of malignant tumors in the mammary gland.
CO.025% in diet for 13.3 months (8). (9) . bBy hepatic microsomes (10, 11) .
a3-MC = 3-methylcholanthrene.
FAA (9, 11 (16) . However, in the mammary gland, induction of hydroxylating enzyme activities was greater after treatment of lactating rats with the larger doses of inducers. The stage of lactation had no effect on the magnitude of induction since similar increases were observed with treatments from the fourth through fourteenth day of lactation, Hydroxylations of benzo(a)pyrene and 2-FAA induced by 3-methylcholanthrene or 3-naphthoflavone in both hepatic and mammary microsomes were inhibited by 0.1 mM a-naphthoflavone (a-NF) in vitro. The a-NF had no significant effect on basal hydroxylating activities (16) . Because a-NF is an inhibitor of cytochrome Pl-450-dependent aryl hydrocarbon hydroxylase in hepatic microsomes (18), we concluded that the increased hydroxylating activities of mammary microsomes were indeed cytochrome P,-450-dependent.
In more recent experiments, we determined the level of each metabolite of 2-FAA formed by mammary microsomes of P-NF-treated lactating and nonlactating (50-day-old) female rats using high performance liquid chromatography (19, 20) . Mammary microsomes from f3-NF-treated lactating rats had a 40 mg/kg of body weight, in corn oil was injected IP on days 5 through 7 of lactation. cThese enzyme assays were described previously (16) . dMitochondrial fractions were suspended in 0.25 M sucrose, 0.025 M Tris-Cl buffer, pH 7.4, to 5 mg/mL protein and were clarified with 1% desoxycholate. Cytochrome c (cc,) and aa3 were determined from change in absorbance AA 550-540 nm (E = 19/mM cm) and 605-630 nm (E = 16/mM cm), respectively, of the difference spectrum of 6 M antimycin A-treated and 7.4 jM PES, 7.5 mM suceinate, 20 mM ascorbate reduced minus 86 M K3Fe(CN)6 oxidized complex. Cytochrome b was calculated from the increase in absorbance at 562-575 nm (E = 25.7/mM cm) upon addition of dithionite to the reduced sample.
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higher metabolic capacity than those of nonlactating rats (Fig. 1 ). This may be explained by enzymatic changes associated with the initiation and maintenance of lactation in the rat mammary gland (21, 22) . Mammary microsomes of lactating rats metabolized 2-FAA to 7-, 5-and 3-hydroxy-2-FAA, as well as to 9-hydroxy-and N-hydroxy-2-FAA. However, no detectable amounts of N-hydroxy-2-FAA were formed by mammary microsomes of nonlactating rats in which 9-hydroxy-2-FAA was a major metabolite.
Comparison of 2-FAA-metabolizing capacities of mammary and hepatic microsomes of the induced lactating and nonlactating rats clearly shows that the liver is the chief site of metabolism of 2-FAA and of its activation via N-hydroxylation ( Table 5 ). The critical role of hepatic metabolism is supported by the results of our earlier studies with disulfiram which inhibited hepatic N-hydroxylation of 2-FAA, thereby reducing its tumorigenicity in the mammary gland (23) . In lactating rats, N-hydroxy-2-FAA produced by mammary microsomes could potentially be excreted in milk contributing to tumorigenicity in the suckling young. In preliminary studies, we found that IP administration of 2-FAA to lactating rats produced low to moderate tumor incidences in both male and female offspring (D. Malejka-Giganti and R. E. Rydell, unpublished experiments). The lack of capacity of mammary microsomes from 50-day-old female rats to N-hydroxylate 2-FAA may explain its weak carcinogenicity on direct application to the mammary gland (11, 24) . It was found in two independent laboratories that 2-FAA, carcinogenic on systemic administration, was only marginally active after one topical administration, whereas N-hydroxy-2-FAA was strongly carcinogenic (Table 6 ). As expected from metabolic studies (Table 3) , a weak systemic carcinogen, 3- FAA, was only marginally active after topical application. In contrast, its hydroxamic acid, N-hydroxy-3-FAA, was considerably more potent (Table 6 ).
Hormone Responsiveness and Cellular Composition of Mammary Tumors
Induction of mammary gland tumors by N-hydroxy-2-FAA and N-hydroxy-3-FAA was dependent on the presence of ovarian hormones in the host.
Ovariectomized rats did not develop tumors, and administration of estrogen starting one week after ovariectomy did not restore carcinogenicity of the hydroxamic acids (11 (25) . The sedimentation values, the association constants of cytoplasmic hormone receptor complexes, and the levels of estradiol and progesterone receptors were comparable to those of mammary carcinomas induced by 7,12-dimethylben(a)anthracene (DMBA) or by methylnitrosourea. The level of 5-a-dihydrotestosterone receptor in the N-hydroxy-2-FAA-induced tumor was twice that in the methylnitrosourea-induced tumor, but was considerably lower than the level of 7S androgen binder in the DMBA-induced tumor. The most prominent difference between the carcinoma induced by N-hydroxy-2-FAA and those induced by the other compounds was the absence of significant amounts of glucocorticoid receptor. This finding may be useful in studies of receptor interactions, e.g., those in which glucocorticoid binding would interfere with that of synthetic progestins.
With cell culture we showed that mammary adenocarcinoma induced in the rat with N-hydroxy-2-FAA involved epithelial and stromal cells of the mammary gland (26) . Malignant transformation of both cell types was confirmed by induction of the respective tumor types after inoculation of subcloned cells into isologous hosts. Our findings are consistent with those of current studies showing that tumors have a heterogeneous cellular composition (27) . Therefore, it will be necessary to assess the role of each type of cell in a target tissue in carcinogen metabolism and activation and to determine if intercellular regulation of metabolic activities occurs. Recent reports indicate that both cell types, rat mammary epithelial cells and mammary fibroblasts grown in vitro, metabolized B[a]P (28, 30) . However, the levels of basal aryl hydrocarbon hydroxylase activity and the patterns of its inducibility by various agents in vitro differed in the two cell types.
Activation of N-Arylacylhydroxamic Acids to Ultimate Carcinogens
The mechanism by which N-hydroxy-2-FAA and other N-arylacylhydroxamic acids initiate tumorigenesis in the rat mammary gland is under investigation in several laboratories. Conversion to an electrophile is still considered the probable mechanism for activation of N-hydroxy-2-FAA. In theory, electrophilic species in the rat mammary gland may be generated from N-hydroxy-2-FAA via an intramolecular N-O-acetyltransfer catalyzed by N-O-acyltransferase, one-electron oxidation to the nitroxyl radical catalyzed by a peroxidase/peroxide system, 179 or conjugation to N-O-glucuronide catalyzed by UDP-glucuronyltransferase (31) . Activation of N-hydroxy-2-FAA via all three mechanisms occurs to a significant extent in the livers of species susceptible and nonsusceptible to hepatocarcinogenesis (32) (33) (34) . Therefore, carcinogenicity does not appear to be determined solely by these activation mechanisms. In the susceptible mammary gland, N-O-acyltransferase-mediated activation of N-hydroxy-2-FAA and of other related carcinogenic hydroxamic acids (Table  6) to N-acyloxyarylamines has been demonstrated (24, 35, 36) . In the case of N-hydroxy-2-FAA, the most carcinogenic compound, this activation was insensitive to paraoxon, a deacylase inhibitor (24) . Activation of the N-propionyl compound was partially inhibited and that of the N-formyl compound was completely inhibited by paraoxon. The mammary gland cytosol was subsequently shown to contain two separable enzymes, one specific for the N-acetyl and N-propionyl compounds and the other specific for the N-formyl compound. Since the N-formyl compound induced several sarcomas in the stromal component of the mammary gland (24) , the distribution of the two N-O-acyltransferase activities among epithelial and stromal cells warrants further investigation. After administration of N-hydroxy-2-FAA to lactating rats, a majority of adducts isolated with ribosomal RNA from the mammary gland lacked the N-acetyl group of the hydroxamic acid (36) . A similar result was obtained with nonlactating rats (37) . These results indicate, although indirectly, that activation of N-hydroxy-2-FAA in the mammary gland can occur via the N-O-acyltransferase mechanism. Activation of the isomeric carcinogenic hydroxamic acid, N-hydroxy-3-FAA, by this mechanism has not been reported.
We are presently investigating one-electron oxidation of the fluorenylhydroxamic acids as a possible route to electrophilic reactants in the mammary gland. Oxidation of carcinogenic aromatic amines to nitroxide free radicals by hepatic microsomal enzymes, presumably the cytochrome P450 system, has been reported (33, 38) . Since mammary microsomes contain a considerably less powerful mixedfunction oxidase than hepatic microsomes (16), we looked for other cytochrome systems that might participate in this oxidation. In contrast to the differences in microsomal enzymes, the content of mitochondrial cytochromes and the cytochrome c oxidase activity were similar in the liver and mammary gland (Table 6) . As mentioned earlier, we found significant amounts of cytochrome aa3, hence, of cytochrome c oxidase activity, in mammary microsomes whose electron micrographs did not show the presence of mitochondrial structures (16) . We attempted to generate nitroxide free radicals of fluorenylhydroxamic acids by the cytochromes present in amounts sufficient for activity in the mammary gland. The ESR spectra of nitroxyl radicals of N-hydroxy-2-FAA and N-hydroxy-3-FAA generated by cytochrome c and hydrogen peroxide are shown in Figure 2 . Generation of these radicals necessitated incubation of cytochrome c with Triton X-100 and peroxide. The nitrogen-splitting constants (8 G) The dismutation product, 2-nitrosofluorene, interacts with -SH groups on proteins to yield fluoreneamine-adducts (Fig. 3) (41) . 2-Nitrosofluorene may also add to double bonds of lipids in an Alder-ene fashion to form a hydroxylamine derivative which undergoes oxidation to yield a fairly stable nitroxyl free radical-lipid adduct (42) . The other dismutation product, an acetate ester of fluorenylhydroxamic acid, may permanently alter DNA (43) or other macromolecules (44, 45) , thus affecting the transcription process.
It is possible that both carcinogen-lipid and carcinogen-DNA interactions are critical in mammary tumorigenesis. Additions of aryl-nitroso compounds to double bonds of lipids (42) or spin-trapping of nitroxyl free radicals of hydroxylamines by membrane components (33) may cause membrane perturbations or structural membrane changes thereby affecting transport. Conceivably, transport of DNAreactive carcinogens could be facilitated through carcinogen-primed membranes. Furthermore, interactions of carcinogens with lipids may be affected by dietary factors which have been shown to alter the lipid content of the mammary gland and to modify chemically induced mammary tumorigenesis in the rat (46, 47) .
Conclusions
Activation of a systemic mammary gland carcinogen, 2-FAA, involves its N-hydroxylation by hepatic mixed function oxidase. Mammary mixed-function oxidase and activation of carcinogens, e.g., N-hydroxylation of 2-FAA, may be induced in response to mammary gland development or to specific environmental factors.
Of the N-arylacylhydroxamic acids tested heretofore, N-hydroxy-2-FAA is the most potent systemic and local mammary carcinogen in the rat.
N-hydroxy-2-FAA-induced mammary adenocarcinoma is hormone-responsive and involves epithelial and stromal components of the rat mammary gland.
Mammary tumorigenesis by N-hydroxy-2-FAA and related N-arylacylhydroxamic acids may involve the interaction of the products of oxidative metabolism with lipids and the interaction of the Nacyloxyarylamine, the N-O-ester or the N-O-glucuronide with DNA or chromatin.
